Bromocriptine induces regression of left ventricular hypertrophy in peritoneal dialysis patients

Proceedings of the Western Pharmacology Society

Volumn 48, Issue , 2005, Pages 122-125

  Mejía Rodríguez, Oliva ^a,b   Alvarez Aguilar, Cleto ^a   Vega Gómez, Helios Eduardo ^a   Belio Caro, Francisco ^a   Vargas Espinosa, Juan M ^c   Paniagua Sierra, José Ramón ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL GENERAL DR MIGUEL SILVA   (Mexico)

^d Unidad de Investigación en Enfermedades Nefrológicas   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; BROMOCRIPTINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FUROSEMIDE; NORADRENALIN;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FEMALE; HEART DEATH; HEART EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; IMAGE ANALYSIS; KIDNEY FAILURE; M MODE ECHOCARDIOGRAPHY; MALE; OPEN STUDY; PREDICTION; PROLACTIN BLOOD LEVEL; STUDENT T TEST;

ADULT; BLOOD PRESSURE; BROMOCRIPTINE; DOPAMINE AGONISTS; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROLACTIN;

EID: 30144433170     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Foley, R.N., Parfrey, P.S., Harnett, J.D., Kent, G.M., Martin, C.J., Murray, D.C. and Barre, P.E. (1995) Kidney Int. 47, 186-192.
2. Culleton, B.F. and Wilson P.F.W. (1998) J. Am. Soc. Nephrol. 9, S5-S15.
3. Middleton, R.J., Parfrey, P.S. and Foley, R.N. (2001) J. Am. Soc. Nephrol. 12, 1079-1084.
4. Lopez-Gomez, J. M., Verde, E. and Perez-Garcia, R. (998) Kidney Int. Suppl. 54, S99-S99.
5. Devereux, R.B. (2000) Am. Heart J. 139, S9-S14.
6. Zoccali, C., Mallamaci, F., Tripepi, G., Parlongo, S., Cutrupi, S., Benedeto, F.A., Cataliotti, A. and Palatino, L.S. (2002) Hipertensión 40(1): 41-46.
7. Dyadyk, A.I., Bagriy, A.E., Lebed, I.A., Yarovaya, N.F., Schukina, E.V. and Taradin, G.G. (1997) Nephrol. Dial. Transplant. 12, 945-951.
8. Kanno, Y., Kaneko, K., Kaneko, M., Kotaki, S., Mimura, T., Takane, H. and Suzuki, H. (2004) J. Cardiovas. Pharmacol. 43, 380-386.
9. Ramirez, G., O'Neill, W.M., Bloomer, H.A. and Jubiz, W. (1977) J. Clin. Edocrinol. & Metab. 45, 658-661.
10. Jose, P.A., Eisner G.M. and Felder, R.A. (1999) Clin. Exp. Pharmacol. & Physiol. 26, S10-S13.
11. Hussain, T., Adbul-Wahab, R., Kotak, A.K. and Lokandowla, M.F. (1998) Hypertension 32, 1054-1059.
12. Sahn, D.D., DeMaria, A., Kisslo, J. and Weyman A. (1978) Circulation 58, 1072-1083.
13. Devereux, R.B., Alonso, D.R., Lutas, E.M., Gottlieb, G.J., Campo, E., Sachs, I. and Reicheck, N. (1986) Am. J. Cardiol. 57, 450-458.
14. Wachtell, K., Bella, J.N., Leibson, P.R., Gerdts, E., Dalhöf, B., Aalto, T., Roman, M.J., Papademetriou, V., Ibsen, H., Rokkedal, J. and Devereux, R.B. (2000) Hypertension. 35, 6-12.
15. Koren, M.J., Casale, P.N., Savage, D.D. and Laragh, J.H. (1991) Ann. Intern. Med., 114, 345-352.
16. Mejía-Rodríguez, O., Alvarez-Aguilar, C., Ledesma-Ramírez, M. and Paniagua-Sierra, R. (2004) Proc. West. Pharmacol. Soc. 47, 122-124.
17. Ganguly, P.K., Lee, S.L., Beamish, R.E. and Dhalla, N.S. (2004) A. Heart J. 118(3), 520-525.
18. Sauro, M.D. and Zone, N.E. (1991) J. Cell. Physiol. 148(1), 133-138.